Peter Habura
About Peter Habura
Peter Habura serves as the Vice President of Quality Assurance at Deciphera Pharmaceuticals, bringing extensive experience in quality operations within the pharmaceutical and biotech industries. He has held various leadership roles throughout his career, including positions at TARIS Bio, Forest Laboratories, and Cubist Pharmaceuticals.
Current Role at Deciphera Pharmaceuticals
Peter Habura serves as the Vice President of Quality Assurance at Deciphera Pharmaceuticals, a position he has held since 2022. In this role, he is responsible for overseeing quality assurance processes and ensuring compliance with regulatory standards within the organization. His work is crucial in maintaining the integrity of the company's products and operations in the Greater Boston area.
Previous Experience at Deciphera Pharmaceuticals
Before his current role, Peter Habura held several positions at Deciphera Pharmaceuticals. He served as the Director of GMP/GDP/GLP Quality from 2018 to 2021, followed by a role as Senior Director of Quality Assurance from 2021 to 2022. His tenure at Deciphera has spanned multiple years, contributing to the company's quality operations and compliance strategies.
Experience at TARIS Bio and Other Companies
Prior to his current position, Peter Habura worked at TARIS Bio as Associate Director of Quality Operations from 2016 to 2018. His career also includes roles at various pharmaceutical companies, such as Cubist Pharmaceuticals, Karyopharm Therapeutics Inc., Forest Laboratories, Kos Pharmaceuticals, and Schering-Plough Corp. His diverse experience spans quality assurance, compliance, and quality systems management.
Educational Background
Peter Habura earned a Bachelor of Science (BS) degree from Kean University. He also holds an Associate of Science (AS) degree from UCNJ Union College of Union County, NJ. His educational background supports his extensive knowledge and expertise in quality assurance within the pharmaceutical and biotech industries.
Expertise in Quality Operations and Regulations
Peter Habura has direct experience in building and leading quality operations from Phase I through to global commercialization in the pharmaceutical, biotech, and medical device sectors. He possesses extensive expertise in international regulations and guidelines related to GxPs, including those from the US FDA, EMA, Health Canada, ANVISA, PMDA, ICH, WHO, ISPE, PIC/S, and IPEC.